EDGAR Filing Documents for 0001387131-17-002008

Form 8-K - Current report:

SEC Accession No. 0001387131-17-002008

Filing Date

2017-04-10

Accepted

2017-04-10 17:15:20

Documents

Period of Report

2017-04-10

Items

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ohr-8k_041017.htm	8-K	21810
2	EXHIBIT 99.1	ex99-1.htm	EX-99.1	9305
3	EXHIBIT 99.2	ex99-2.htm	EX-99.2	10819
4	GRAPHIC	image_002.jpg	GRAPHIC	15133
	Complete submission text file	0001387131-17-002008.txt		64301

Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022

Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452

Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)